An exploratory study of sorafenib plus toripalimab for unresectable hepatocellular carcinoma with portal vein tumor thrombus.

被引：0
|
作者：
Yang, Yu [1 ]
Li, Qiu [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Canc Ctr, Dept Med Oncol, Chengdu, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS4658
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TACE Plus Lenvatinib Versus TACE Plus Sorafenib for Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Cohort Study
    Yang, Biao
    Jie, Luo
    Yang, Ting
    Chen, Mingyang
    Gao, Yuemei
    Zhang, Tian
    Zhang, Yuzu
    Wu, Hao
    Liao, Zhengyin
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] Pilot study of local radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma
    Yamada, K
    Soejima, T
    Sugimoto, K
    Mayahara, H
    Izaki, K
    Sasaki, R
    Maruta, T
    Matsumoto, S
    Hirota, S
    Sugimura, K
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (04) : 147 - 152
  • [3] Hepatocellular carcinoma with portal vein tumor thrombus
    Sniderman, KW
    [J]. RADIOLOGY, 1998, 207 (02) : 552 - 553
  • [4] The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
    Yingqiang Zhang
    Hongfei Miao
    Wenlin Xie
    Suxiang Jiang
    Ze Song
    Guihua Huang
    Wenzhe Fan
    Yu Wang
    Jiaping Li
    Yong Chen
    [J]. European Radiology, 2021, 31 : 232 - 243
  • [5] The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization
    Zhang, Yingqiang
    Miao, Hongfei
    Xie, Wenlin
    Jiang, Suxiang
    Song, Ze
    Huang, Guihua
    Fan, Wenzhe
    Wang, Yu
    Li, Jiaping
    Chen, Yong
    [J]. EUROPEAN RADIOLOGY, 2021, 31 (01) : 232 - 243
  • [6] Conversion Therapy of Large Unresectable Hepatocellular Carcinoma With Ipsilateral Portal Vein Tumor Thrombus Using Portal Vein Embolization Plus Transcatheter Arterial Chemoembolization
    He, Chengjian
    Ge, Naijian
    Wang, Xiangdong
    Li, Hai
    Chen, Shiguang
    Yang, Yefa
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Survival benefit of TACE combined with sorafenib for hepatocellular carcinoma patients with portal vein tumor thrombus
    Luo, Bin
    Chen, Zhen-Hua
    Zhang, Xiu-Ping
    Wang, Meng
    Cheng, Shu-Qun
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S293 - S295
  • [8] Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Nagai, Hidenari
    Mukozu, Takanori
    Ogino, Yu
    Matsui, Daigo
    Matsui, Teppei
    Wakui, Noritaka
    Momiyama, Koichi
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    Higai, Koji
    [J]. ANTICANCER RESEARCH, 2015, 35 (04) : 2269 - 2277
  • [9] Hepatocellular carcinoma with portal vein tumor thrombus - Response
    Furuse, J
    Iwasaki, M
    Yoshino, M
    Konishi, M
    Kawano, N
    Kinoshita, T
    Ryu, M
    Satake, M
    Moriyama, N
    [J]. RADIOLOGY, 1998, 207 (02) : 553 - 553
  • [10] Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus
    Toshiya Kamiyama
    Tatsuhiko Kakisaka
    Tatsuya Orimo
    Kenji Wakayama
    [J]. World Journal of Hepatology, 2017, (36) : 1296 - 1304
12345